A detailed history of Strs Ohio transactions in Alkermes Plc. stock. As of the latest transaction made, Strs Ohio holds 13,600 shares of ALKS stock, worth $403,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,600
Previous 12,600 7.94%
Holding current value
$403,240
Previous $303,000 25.41%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$23.01 - $28.55 $23,010 - $28,550
1,000 Added 7.94%
13,600 $380,000
Q2 2024

Aug 05, 2024

SELL
$23.21 - $27.24 $13,926 - $16,343
-600 Reduced 4.55%
12,600 $303,000
Q1 2024

May 13, 2024

SELL
$26.4 - $32.56 $330,000 - $407,000
-12,500 Reduced 48.64%
13,200 $357,000
Q4 2023

Jan 30, 2024

SELL
$23.37 - $28.68 $588,924 - $722,736
-25,200 Reduced 49.51%
25,700 $712,000
Q3 2023

Oct 26, 2023

BUY
$27.17 - $31.97 $1.38 Million - $1.63 Million
50,900 New
50,900 $1.43 Million
Q1 2023

Aug 02, 2023

BUY
$25.31 - $29.02 $521,386 - $597,812
20,600 New
20,600 $580,000
Q1 2023

Apr 27, 2023

SELL
$25.31 - $29.02 $493,545 - $565,890
-19,500 Reduced 48.63%
20,600 $580,000
Q4 2022

Jan 26, 2023

SELL
$21.94 - $26.24 $239,146 - $286,016
-10,900 Reduced 21.37%
40,100 $1.05 Million
Q3 2022

Oct 27, 2022

BUY
$22.0 - $31.87 $57,200 - $82,862
2,600 Added 5.37%
51,000 $1.14 Million
Q2 2022

Jul 25, 2022

BUY
$26.4 - $30.54 $916,080 - $1.06 Million
34,700 Added 253.28%
48,400 $1.44 Million
Q4 2021

Jan 24, 2022

SELL
$21.47 - $32.08 $794,390 - $1.19 Million
-37,000 Reduced 72.98%
13,700 $318,000
Q3 2021

Oct 22, 2021

BUY
$23.37 - $32.13 $962,844 - $1.32 Million
41,200 Added 433.68%
50,700 $1.56 Million
Q2 2021

Jul 26, 2021

BUY
$18.78 - $25.15 $178,410 - $238,925
9,500 New
9,500 $232,000
Q4 2020

Jan 25, 2021

SELL
$15.39 - $22.1 $29,133 - $41,835
-1,893 Closed
0 $0
Q3 2020

Dec 14, 2020

BUY
$16.16 - $20.66 $30,590 - $39,109
1,893 New
1,893 $31,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.